Novo Nordisk Archives

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

// Biotech and Pharma Therapeutics Following Boehringer’s lead, AstraZeneca ⁠caps monthly out-of-pocket inhaler costs at $35 in the US March 18, 2024 / AstraZeneca / Symbicort / Inhaled Medicines / Asthma AstraZeneca on Monday revealed it’s expanding a savings program...

April 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

March 28, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 21, 2024

March 21, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 15, 2024

// Biotech and Pharma Therapeutics Can biotechnology lead the way toward a sustainable pharmaceutical industry? March 14, 2024 / Biotechnology / Sustainability / PharmaceuticalsExamine the environmental sustainability of the pharmaceutical industry, highlighting that only a small fraction of drugs have...

March 15, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

// Biotech and Pharma Therapeutics Endocrinology company Valendo Health launches with $4M and two provider partners January 31, 2024 / Endocrinology / Diabetes / Telehealth Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed...

February 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

// Biotech and Pharma Therapeutics Lilly gene therapy finding puts focus on hearing loss treatment pipeline January 24, 2024 / Eli Lilly / Gene Therapy / Drug Target / Hearing loss An 11-year-old boy who was born deaf can hear...

January 26, 2024

1 2 … 5 6

Tag: Novo Nordisk

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

Healthcare Industry News Weekly Wrap-Up: March 21, 2024

Healthcare Industry News Weekly Wrap-Up: March 15, 2024

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Novo Nordisk

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺